These data demonstrate that LDHA is overexpressed in pancreatic cancer compared to its normal adjacent tissue, and LDHA overexpression results in poor clinical outcomes in pancreatic adenocarcinoma patients. The gene discussed is LDHA; the disease is familial pancreatic carcinoma.